SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3naf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E73_M_ASCM995_0 (MYROSINASE MA1)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	ILE A1014 ARG A1016 TYR A 996 PHE A 558	None	1.45A	1e73M-3nafA: undetectable	1e73M-3nafA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ERR_A_RALA600_2 (ESTROGEN RECEPTOR)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	LEU A 425 LEU A 461 LEU A 387 LEU A 390	None	0.89A	1errA-3nafA: undetectable	1errA-3nafA: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KQW_A_RTLA135_0 (CELLULAR RETINOL-BINDING PROTEIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 12	ILE A 937 THR A1035 LEU A 507 LEU A 564 ILE A 566	None	1.14A	1kqwA-3nafA: undetectable	1kqwA-3nafA: 10.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S9P_B_DESB459_2 (ESTROGEN-RELATED RECEPTOR GAMMA)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	LEU A 387 HIS A 379 ILE A 381	None	0.68A	1s9pB-3nafA: undetectable	1s9pB-3nafA: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IGT_A_SAMA1001_1 (SAM DEPENDENT METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	ASP A 817 ASP A 812 ASP A 885	None	0.73A	2igtA-3nafA: 6.0	2igtA-3nafA: 16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IGT_B_SAMB1002_1 (SAM DEPENDENT METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	ASP A 817 ASP A 812 ASP A 885	None	0.72A	2igtB-3nafA: 2.4	2igtB-3nafA: 16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_A_SAMA302_1 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	THR A 939 ASP A 666 SER A 688	None	0.83A	2nxeA-3nafA: 6.7	2nxeA-3nafA: 14.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NXE_B_SAMB303_1 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	THR A 939 ASP A 666 SER A 688	None	0.75A	2nxeB-3nafA: 6.7	2nxeB-3nafA: 14.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_B_ASDB1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	PHE A 596 LEU A 662 LEU A 580 ALA A 567	None	0.99A	2vcvB-3nafA: undetectable	2vcvB-3nafA: 13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_K_ASDK1224_1 (GLUTATHIONE S-TRANSFERASE A3)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	PHE A 596 LEU A 662 LEU A 580 ALA A 567	None	0.96A	2vcvK-3nafA: undetectable	2vcvK-3nafA: 13.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VXA_G_RBFG200_1 (DODECIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 8	HIS A 586 TYR A 570 THR A 593 GLN A 590	None	1.36A	2vxaF-3nafA: undetectable 2vxaG-3nafA: undetectable 2vxaI-3nafA: undetectable	2vxaF-3nafA: 6.92 2vxaG-3nafA: 6.92 2vxaI-3nafA: 6.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_B_P1ZB1356_1 (PROSTAGLANDIN REDUCTASE 2)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 8	ILE A 598 TYR A 996 LEU A1052 VAL A 977	None	0.88A	2w98B-3nafA: 3.7	2w98B-3nafA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZSE_A_PAUA600_0 (PANTOTHENATE KINASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 7	TYR A 463 ARG A 735 MET A 739 PHE A 692	None	1.15A	2zseA-3nafA: undetectable	2zseA-3nafA: 17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AF3_A_PAUA314_0 (PANTOTHENATE KINASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	TYR A 463 ARG A 735 MET A 739 PHE A 692	None	1.07A	3af3A-3nafA: undetectable	3af3A-3nafA: 17.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEO_A_SAMA328_1 (MODIFICATION METHYLASE HHAI)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	GLU A 709 SER A 777 VAL A 755	None	0.83A	3eeoA-3nafA: 3.7	3eeoA-3nafA: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKP_C_478C200_1 (PROTEASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 10	ASP A 410 VAL A 414 ILE A 424 ALA A 419 ILE A 416	None	0.96A	3ekpC-3nafA: undetectable	3ekpC-3nafA: 9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_B_017B200_2 (PROTEASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 9	ASP A 410 VAL A 414 ILE A 424 ALA A 419 ILE A 416	None	0.98A	3ektB-3nafA: undetectable	3ektB-3nafA: 9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3I45_A_NIOA500_1 (TWIN-ARGININE TRANSLOCATION PATHWAY SIGNAL PROTEIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 8	PHE A 756 LEU A 803 TYR A 762 LEU A 491	None	1.01A	3i45A-3nafA: 4.8	3i45A-3nafA: 18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TGV_C_BEZC1_0 (HEME-BINDING PROTEIN HUTZ)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	TYR A1007 PHE A 987 PRO A 986 LEU A 980	None	1.46A	3tgvC-3nafA: undetectable	3tgvC-3nafA: 11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UJ6_A_SAMA300_1 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 4	SER A 728 ASP A 432 ASP A 437 ALA A 730	None	1.15A	3uj6A-3nafA: 5.0	3uj6A-3nafA: 15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQ6_B_ADNB401_2 (ADENOSINE KINASE, PUTATIVE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	LEU A 503 GLY A 502 PHE A 493 ASN A 509	None	1.32A	3uq6B-3nafA: 3.3	3uq6B-3nafA: 18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_D_ACTD502_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	GLY A 531 THR A1035 ASN A 509	None	0.68A	3v4tD-3nafA: 2.7	3v4tD-3nafA: 20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DM8_A_REAA501_1 (RETINOIC ACID RECEPTOR BETA)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 11	LEU A 387 LEU A 353 SER A 814 LEU A 360 LEU A 425	None	1.03A	4dm8A-3nafA: undetectable	4dm8A-3nafA: 14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	TYR A1015 GLN A 501 GLY A 502 SER A 504	None	0.68A	4fu8A-3nafA: undetectable	4fu8A-3nafA: 16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1A_A_AB1A101_2 (MDR769 HIV-1 PROTEASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	ASN A 380 ASP A 410 GLY A 333 PRO A 383	None	1.09A	4l1aB-3nafA: undetectable	4l1aB-3nafA: 9.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O4D_A_ACTA406_0 (INOSITOL HEXAKISPHOSPHATE KINASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 7	ARG A 972 PHE A 746 SER A 744 HIS A 693	None	1.43A	4o4dA-3nafA: undetectable	4o4dA-3nafA: 14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZB_D_ACTD403_0 (PROTON-GATED ION CHANNEL)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 4	ILE A 953 ARG A 938 TYR A 463 GLU A 488	None	1.12A	4zzbD-3nafA: undetectable	4zzbD-3nafA: 16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZC_E_ACTE406_0 (PROTON-GATED ION CHANNEL)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	ILE A 953 ARG A 938 TYR A 463 GLU A 488	None	1.18A	4zzcE-3nafA: undetectable	4zzcE-3nafA: 16.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKT_B_TLFB601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 12	VAL A 719 LEU A 503 GLY A 492 ALA A 495 LEU A 741	None	1.17A	5iktB-3nafA: undetectable	5iktB-3nafA: 19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KPC_A_SAMA401_1 (PAVINE N-METHYLTRANSFERASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	PHE A 359 SER A 357 ASN A 440 GLN A 459	None	1.29A	5kpcA-3nafA: undetectable	5kpcA-3nafA: 19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MRA_B_DM2B204_1 (SORCIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	TYR A 528 PHE A 909 ARG A 514 GLY A 531	None	1.16A	5mraA-3nafA: undetectable 5mraB-3nafA: undetectable	5mraA-3nafA: 12.27 5mraB-3nafA: 12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUG_A_VIVA301_1 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	3 / 3	SER A 512 SER A 922 PHE A 909	None	0.93A	5mugA-3nafA: undetectable	5mugA-3nafA: 15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TUI_B_CTCB405_0 (TETRACYCLINE DESTRUCTASE TET(50))	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	5 / 12	GLY A1013 LEU A 503 GLY A 912 GLY A 531 ILE A 598	None	0.86A	5tuiB-3nafA: 2.9	5tuiB-3nafA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_A_ACRA1421_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	TYR A 401 TYR A 332 GLY A 333 GLY A 334	None	0.97A	5x7pA-3nafA: 2.9	5x7pA-3nafA: 19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_B_ACRB1421_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	TYR A 401 TYR A 332 GLY A 333 GLY A 334	None	0.97A	5x7pB-3nafA: undetectable	5x7pB-3nafA: 19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GBN_B_ADNB501_2 (-)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 5	GLN A 459 THR A 458 HIS A 464 LEU A 461	None	1.40A	6gbnB-3nafA: 5.0	6gbnB-3nafA: 20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN4_C_AM2C301_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE, AAC(3)-IVA)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 8	ASP A 812 HIS A 350 GLU A 354 GLU A 386	None	1.31A	6mn4C-3nafA: undetectable	6mn4C-3nafA: 15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MVX_A_K4DA1304_0 (ION TRANSPORT PROTEIN)	3naf	CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTI VATED POTASSIUM CHANNEL SUBUNIT ALPHA-1 (Homo sapiens)	4 / 6	THR A 935 LEU A 936 THR A 946 LEU A 580	None	1.13A	6mvxA-3nafA: undetectable 6mvxB-3nafA: undetectable 6mvxC-3nafA: undetectable	6mvxA-3nafA: 16.20 6mvxB-3nafA: 16.20 6mvxC-3nafA: 16.20

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E73_M_ASCM995_0","MYROSINASE MA1","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ILE A1014;ARG A1016;TYR A 996;PHE A 558","None","1.45A","1e73M-3nafA:undetectable","1e73M-3nafA:20.91"],["1ERR_A_RALA600_2","ESTROGEN RECEPTOR","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"LEU A 425;LEU A 461;LEU A 387;LEU A 390","None","0.89A","1errA-3nafA:undetectable","1errA-3nafA:16.58"],["1KQW_A_RTLA135_0","CELLULAR RETINOL-BINDING PROTEIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"ILE A 937;THR A1035;LEU A 507;LEU A 564;ILE A 566","None","1.14A","1kqwA-3nafA:undetectable","1kqwA-3nafA:10.82"],["1S9P_B_DESB459_2","ESTROGEN-RELATED RECEPTOR GAMMA","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"LEU A 387;HIS A 379;ILE A 381","None","0.68A","1s9pB-3nafA:undetectable","1s9pB-3nafA:14.29"],["2IGT_A_SAMA1001_1","SAM DEPENDENT METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"ASP A 817;ASP A 812;ASP A 885","None","0.73A","2igtA-3nafA:6.0","2igtA-3nafA:16.33"],["2IGT_B_SAMB1002_1","SAM DEPENDENT METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"ASP A 817;ASP A 812;ASP A 885","None","0.72A","2igtB-3nafA:2.4","2igtB-3nafA:16.33"],["2NXE_A_SAMA302_1","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"THR A 939;ASP A 666;SER A 688","None","0.83A","2nxeA-3nafA:6.7","2nxeA-3nafA:14.82"],["2NXE_B_SAMB303_1","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"THR A 939;ASP A 666;SER A 688","None","0.75A","2nxeB-3nafA:6.7","2nxeB-3nafA:14.82"],["2VCV_B_ASDB1224_1","GLUTATHIONE S-TRANSFERASE A3","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"PHE A 596;LEU A 662;LEU A 580;ALA A 567","None","0.99A","2vcvB-3nafA:undetectable","2vcvB-3nafA:13.88"],["2VCV_K_ASDK1224_1","GLUTATHIONE S-TRANSFERASE A3","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"PHE A 596;LEU A 662;LEU A 580;ALA A 567","None","0.96A","2vcvK-3nafA:undetectable","2vcvK-3nafA:13.88"],["2VXA_G_RBFG200_1","DODECIN;DODECIN;DODECIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"HIS A 586;TYR A 570;THR A 593;GLN A 590","None","1.36A","2vxaF-3nafA:undetectable;2vxaG-3nafA:undetectable;2vxaI-3nafA:undetectable","2vxaF-3nafA:6.92;2vxaG-3nafA:6.92;2vxaI-3nafA:6.92"],["2W98_B_P1ZB1356_1","PROSTAGLANDIN REDUCTASE 2","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ILE A 598;TYR A 996;LEU A1052;VAL A 977","None","0.88A","2w98B-3nafA:3.7","2w98B-3nafA:18.07"],["2ZSE_A_PAUA600_0","PANTOTHENATE KINASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A 463;ARG A 735;MET A 739;PHE A 692","None","1.15A","2zseA-3nafA:undetectable","2zseA-3nafA:17.08"],["3AF3_A_PAUA314_0","PANTOTHENATE KINASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A 463;ARG A 735;MET A 739;PHE A 692","None","1.07A","3af3A-3nafA:undetectable","3af3A-3nafA:17.08"],["3EEO_A_SAMA328_1","MODIFICATION METHYLASE HHAI","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"GLU A 709;SER A 777;VAL A 755","None","0.83A","3eeoA-3nafA:3.7","3eeoA-3nafA:17.57"],["3EKP_C_478C200_1","PROTEASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"ASP A 410;VAL A 414;ILE A 424;ALA A 419;ILE A 416","None","0.96A","3ekpC-3nafA:undetectable","3ekpC-3nafA:9.70"],["3EKT_B_017B200_2","PROTEASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"ASP A 410;VAL A 414;ILE A 424;ALA A 419;ILE A 416","None","0.98A","3ektB-3nafA:undetectable","3ektB-3nafA:9.70"],["3I45_A_NIOA500_1","TWIN-ARGININE TRANSLOCATION PATHWAY SIGNAL PROTEIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"PHE A 756;LEU A 803;TYR A 762;LEU A 491","None","1.01A","3i45A-3nafA:4.8","3i45A-3nafA:18.47"],["3TGV_C_BEZC1_0","HEME-BINDING PROTEIN HUTZ","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A1007;PHE A 987;PRO A 986;LEU A 980","None","1.46A","3tgvC-3nafA:undetectable","3tgvC-3nafA:11.26"],["3UJ6_A_SAMA300_1","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"SER A 728;ASP A 432;ASP A 437;ALA A 730","None","1.15A","3uj6A-3nafA:5.0","3uj6A-3nafA:15.66"],["3UQ6_B_ADNB401_2","ADENOSINE KINASE, PUTATIVE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"LEU A 503;GLY A 502;PHE A 493;ASN A 509","None","1.32A","3uq6B-3nafA:3.3","3uq6B-3nafA:18.31"],["3V4T_D_ACTD502_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"GLY A 531;THR A1035;ASN A 509","None","0.68A","3v4tD-3nafA:2.7","3v4tD-3nafA:20.60"],["4DM8_A_REAA501_1","RETINOIC ACID RECEPTOR BETA","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"LEU A 387;LEU A 353;SER A 814;LEU A 360;LEU A 425","None","1.03A","4dm8A-3nafA:undetectable","4dm8A-3nafA:14.43"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A1015;GLN A 501;GLY A 502;SER A 504","None","0.68A","4fu8A-3nafA:undetectable","4fu8A-3nafA:16.06"],["4L1A_A_AB1A101_2","MDR769 HIV-1 PROTEASE;MDR769 HIV-1 PROTEASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ASN A 380;ASP A 410;GLY A 333;PRO A 383","None","1.09A","4l1aB-3nafA:undetectable","4l1aB-3nafA:9.02"],["4O4D_A_ACTA406_0","INOSITOL HEXAKISPHOSPHATE KINASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ARG A 972;PHE A 746;SER A 744;HIS A 693","None","1.43A","4o4dA-3nafA:undetectable","4o4dA-3nafA:14.41"],["4ZZB_D_ACTD403_0","PROTON-GATED ION CHANNEL","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ILE A 953;ARG A 938;TYR A 463;GLU A 488","None","1.12A","4zzbD-3nafA:undetectable","4zzbD-3nafA:16.35"],["4ZZC_E_ACTE406_0","PROTON-GATED ION CHANNEL","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ILE A 953;ARG A 938;TYR A 463;GLU A 488","None","1.18A","4zzcE-3nafA:undetectable","4zzcE-3nafA:16.56"],["5IKT_B_TLFB601_0","PROSTAGLANDIN G\/H SYNTHASE 2","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"VAL A 719;LEU A 503;GLY A 492;ALA A 495;LEU A 741","None","1.17A","5iktB-3nafA:undetectable","5iktB-3nafA:19.60"],["5KPC_A_SAMA401_1","PAVINE N-METHYLTRANSFERASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"PHE A 359;SER A 357;ASN A 440;GLN A 459","None","1.29A","5kpcA-3nafA:undetectable","5kpcA-3nafA:19.65"],["5MRA_B_DM2B204_1","SORCIN;SORCIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A 528;PHE A 909;ARG A 514;GLY A 531","None","1.16A","5mraA-3nafA:undetectable;5mraB-3nafA:undetectable","5mraA-3nafA:12.27;5mraB-3nafA:12.27"],["5MUG_A_VIVA301_1","ALPHA-TOCOPHEROL TRANSFER PROTEIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",3,"SER A 512;SER A 922;PHE A 909","None","0.93A","5mugA-3nafA:undetectable","5mugA-3nafA:15.15"],["5TUI_B_CTCB405_0","TETRACYCLINE DESTRUCTASE TET(50)","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",5,"GLY A1013;LEU A 503;GLY A 912;GLY A 531;ILE A 598","None","0.86A","5tuiB-3nafA:2.9","5tuiB-3nafA:19.41"],["5X7P_A_ACRA1421_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A 401;TYR A 332;GLY A 333;GLY A 334","None","0.97A","5x7pA-3nafA:2.9","5x7pA-3nafA:19.77"],["5X7P_B_ACRB1421_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"TYR A 401;TYR A 332;GLY A 333;GLY A 334","None","0.97A","5x7pB-3nafA:undetectable","5x7pB-3nafA:19.77"],["6GBN_B_ADNB501_2","-","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"GLN A 459;THR A 458;HIS A 464;LEU A 461","None","1.40A","6gbnB-3nafA:5.0","6gbnB-3nafA:20.37"],["6MN4_C_AM2C301_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE, AAC(3)-IVA","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"ASP A 812;HIS A 350;GLU A 354;GLU A 386","None","1.31A","6mn4C-3nafA:undetectable","6mn4C-3nafA:15.74"],["6MVX_A_K4DA1304_0","ION TRANSPORT PROTEIN","3naf","CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1,CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1","Homo sapiens",4,"THR A 935;LEU A 936;THR A 946;LEU A 580","None","1.13A","6mvxA-3nafA:undetectable;6mvxB-3nafA:undetectable;6mvxC-3nafA:undetectable","6mvxA-3nafA:16.20;6mvxB-3nafA:16.20;6mvxC-3nafA:16.20"]]